| Filed On | Filing |
|---|---|
| 13 Nov 2026 |
8-K: Other Events
On November 12, 2026, Tandem Diabetes Care, Inc. (the “Company”) received 510(k) clearance from the U.S. Food and Drug Administration for Tandem Mobi, the world’s first and only tubeless automated insulin delivery system with up to 7 day... |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
San Diego, November 5, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2026. |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
San Diego, August 6, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026. |
| 21 May 2026 |
8-K: Material Modification to Rights of Security Holders; Departure/Election of Directors or Officers; Compensation +1 more
1.1Purposes. The purposes of the Plan are (a) to enhance the Company’s ability to attract and retain the services of qualified employees, officers, directors, consultants and other service providers upon whose judgment, initiative and ef... |
| 15 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause. Mr. Novara’s last... |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition
San Diego, May 7, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance fo... |
| 27 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
INDENTURE dated as of February 27, 2026 between TANDEM DIABETES CARE, INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking ... |
| 19 Feb 2026 |
8-K: Results of Operations and Financial Condition
San Diego, February 19, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provide... |
| 30 Dec 2025 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
Section 1. Registered Office. The registered office of Tandem Diabetes Care, Inc. (the “Corporation”) shall be fixed in the Corporation’s Certificate of Incorporation, as the same may be amended and/or restated from time to time (as so a... |
| 12 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
SAN DIEGO, November 12, 2025 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. ... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
San Diego, November 6, 2025 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 20... |
| 07 Aug 2025 |
8-K: Other Events
On August 6, 2025, Tandem Diabetes Care, Inc. (the “Company”) received 510(k) clearance from the U.S. Food and Drug Administration for the SteadiSet™ infusion set (“SteadiSet”) for up to seven days of use. SteadiSet is a wearable infusio... |
| 06 Aug 2025 |
8-K: Results of Operations and Financial Condition
San Diego, August 6, 2025 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance. |
| 23 May 2025 |
8-K: Entry into a Material Definitive Agreement; Submission of Matters to a Vote of Security Holders
On May 21, 2025 (the “Effective Date”), Tandem Diabetes Care, Inc. (the “Company”), Tandem Diabetes Care Europe B.V. (with the Company, the “Company Entities”), F. Hoffmann-La Roche AG, Roche Diabetes Care GmbH, Roche Diabetes Care, Inc.... |
| 20 May 2025 |
8-K: Other Events
On May 16, 2025, Tandem Diabetes Care, Inc. (the Company) received CE mark approval for the Tandem Mobi insulin delivery system with Control-IQ+ technology. |
| 12 May 2025 |
8-K: Other Events
On May 9, 2025, SteadiSet Infusion Set (SteadiSet) received 510(k) clearance from the United States Food and Drug Administration (FDA) for up to three days of use. SteadiSet is a wearable infusion set that delivers insulin from an insuli... |
| 30 Apr 2025 |
8-K: Results of Operations and Financial Condition
San Diego, April 30, 2025 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025. |
| 26 Feb 2025 |
8-K: Results of Operations and Financial Condition
San Diego, February 26, 2025 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2024 and provide... |
| 06 Nov 2024 |
8-K: Results of Operations and Financial Condition
San Diego, November 6, 2024 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2024 and increased sales guidanc... |
| 01 Aug 2024 |
8-K: Results of Operations and Financial Condition
San Diego, August 1, 2024 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2024 and increased sales guidance for t... |
Loading...